|
1
|
Papadas TA, Alexopoulos EC, Mallis A,
Jelastopulu E, Mastronikolis NS and Goumas P: Survival after
laryngectomy: A review of 133 patients with laryngeal carcinoma.
Eur Arch Otorhinolaryngol. 267:1095–1101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shah JP, Karnell LH, Hoffman HT, Ariyan S,
Brown GS, Fee WE, Glass AG, Goepfert H, Ossoff RH and Fremgen A:
Patterns of care for cancer of the larynx in the United States.
Arch Otolaryngol Head Neck Surg. 123:475–483. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jose J, Coatesworth AP, Johnston C and
MacLennan K: Cervical node metastases in squamous cell carcinoma of
the of upper aerodigestive tract: The significance of extracapsular
spread and soft tissue deposits. Head Neck. 25:451–456. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pei L and Melmed S: Isolation and
characterization of a pituitary tumor-transforming gene (PTTG). Mol
Endocrinol. 11:433–441. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Demeure MJ, Coan KE, Grant CS, Komorowski
RA, Stephan E, Sinari S, Mount D and Bussey KJ: PTTG1
overexpression in adrenocortical cancer is associated with poor
survival and represents a potential therapeutic target. Surgery.
154:1405–1416. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ramaswamy S, Ross KN, Lander ES and Golub
TR: A molecular signature of metastasis in primary solid tumors.
Nat Genet. 33:49–54. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Solbach C, Roller M, Eckerdt F, Peters S
and Knecht R: Pituitary tumor-transforming gene expression is a
prognostic marker for tumor recurrence in squamous cell carcinoma
of the head and neck. BMC Cancer. 6:2422006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Langenskiold M, Holmdahl L, Falk P and
Ivarsson ML: Increased plsama MMP-2 protein expression in lymph
node-positive patients with colorectal cancer. Int J Colorectal
Dis. 20:245–252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Edge SB and Compton CC: The American Joint
Committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park SS, Kim JE, Kim YA, Kim YC and Kim
SW: Caveolin-1 is down-regulated and inversely correlated with HER2
and EGFR expression status in invasive ductal carcinoma of the
breast. Histopathology. 47:625–630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Towbin H, Staehelin T and Gordon J:
Electrophoretic transfer of proteins from polyacrylamide gels to
nitrocellulose sheets: Procedure and some applications. Proc Natl
Acad Sci USA. 76:4350–4354. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Starska K, Forma E, Jóźwiak P, Bryś M,
Lewy-Trenda I, Brzezińska-Błaszczyk E and Krześlak A: Gene and
protein expression of glucose transporter 1 and glucose transporter
3 in human laryngeal cancer-the relationship with regulatory
hypoxia-inducible factor-1α expression, tumor invasiveness, and
patient prognosis. Tumor Biol. 36:2309–2321. 2015. View Article : Google Scholar
|
|
13
|
Hoffman HT, Porter K, Karnell LH, Cooper
JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A and Robinson RA:
Laryngeal cancer in the United States: Changes in demographics,
patterns of care, and survival. Laryngoscope. 116(Suppl 111):
S1–S13. 2006. View Article : Google Scholar
|
|
14
|
Carvalho AL, Nishimoto IN, Califano JA and
Kowalski LP: Trends in incidence and prognosis for head and neck
cancer in the United States: A site-specific analysis of the SEER
database. Int J cancer. 114:806–816. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ramos-Morales F, Dominguez A, Romero F,
Luna R, Multon MC, Pintor-Toro JA and Tortolero M: Cell cycle
regulated expression and phosphorylation of hpttg proto-oncogene
product. Oncogene. 19:403–409. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Solbach C, Roller M, Fellbaum C, Nicoletti
M and Kaufmann M: PTTG mRNA expression in primary breast cancer: A
prognostic marker for lymph node invasion and tumor recurrence.
Breast. 13:80–81. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rehfeld N, Geddert H, Atamna A, Rohrbeck
A, Garcia G, Kliszewski S, Neukirchen J, Bruns I, Steidl U, Fenk R,
et al: The influence of the pituitary tumor transforming gene-1
(PTTG-1) on survival of patients with small cell lung cancer and
non-small cell lung cancer. J Carcinog. 5:42006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smith VE, Franklyn JA and McCabe CJ:
Pituitary tumor-transforming gene and its binding factor in
endocrine cancer. Expert Rev Mol Med. 12:e382010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pei L: Activation of mitogen-activated
protein kinase cascade regulates pituitary tumor-transforming gene
transactivation function. J Biol Chem. 275:31191–31198. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heaney AP, Singson R, McCabe CJ, Nelson V,
Nakashima M and Melmed S: Expression of pituitary-tumour
transforming gene in colorectal tumours. Lancet. 355:716–719. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Heaney AP, Horwitz GA, Wang Z, Singson R
and Melmed S: Early involvement of estrogen-induced pituitary tumor
transforming gene and fibroblast growth factor expression in
prolactinoma pathogenesis. Nat Med. 5:1317–1321. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim DS, Franklyn JA, Stratford AL,
Boelaert K, Watkinson JC, Eggo MC and McCabe CJ: Pituitary
tumor-transforming gene regulates multiple downstream angiogenic
genes in thyroid cancer. J Clin Endocrinol Metab. 91:1119–1128.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Westermarck J and Kähäri VM: Regulation of
matrix metalloproteinase expression in tumor invasion. FASEB J.
13:781–792. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Itoh Y and Nagase H: Matrix
metalloproteinases in cancer. Essays Biochem. 38:21–36. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Curran S and Murray GI: Matrix
metalloproteinases: Molecular aspects of their roles in tumour
invasion and metastasis. Eur J Cancer. 36:1621–1630. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dunér S, Lopatko Lindman J, Ansari D,
Gundewar C and Andersson R: Pancreatic cancer: The role of
pancreatic stellate cells in tumor progression. Pancreatology.
10:673–681. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Parsons SL, Watson SA, Collins HM, Griffin
NR, Clarke PA and Steele RJ: Gelatinase (MMP-2 and −9) expression
in gastrointestinal malignancy. Br J Cancer. 78:1495–1502. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Christopoulos TA, Papageorgakopoulou N,
Ravazoula P, Mastronikolis NS, Papadas TA, Theocharis DA and Vynios
DH: Expression of metalloproteinases and their tissue inhibitors in
squamous cell laryngeal carcinoma. Oncol Rep. 18:855–860.
2007.PubMed/NCBI
|
|
29
|
Saussez S, Cludts S, Capouillez A,
Mortuaire G, Smetana K Jr, Kaltner H, André S, Leroy X, Gabius HJ
and Decaestecker C: Identification of matrix metalloproteinase-9 as
an independent prognostic marker in laryngeal and hypopharyngeal
cancer with opposite correlations to adhesion/growth-regulatory
galectins-1 and −7. Int J Oncol. 34:433–439. 2009.PubMed/NCBI
|
|
30
|
Malik MT and Kakar SS: Regulation of
angiogenesis and invasion by human pituitary tumor transforming
gene (PTTG) through increased expression and secretion of matrix
metalloproteinases-2 (MMP-2). Mol Cancer. 5:612006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lim BJ, Jung SS, Choi SY and Lee CS:
Expression of metastasis associated molecules in non-small cell
lung cancer and their prognostic significance. Mol Med Rep.
3:43–49. 2010.PubMed/NCBI
|
|
32
|
Li H, Yin C, Zhan B, Sun Y, Shi L, Liu N,
Liang S, Lu S, Liu Y, Zhang J, et al: PTTG1 promotes migration and
invasion of human non-small cell lung cancer cells and is modulated
by miR-186. Carcinogenesis. 34:2145–2155. 2013. View Article : Google Scholar : PubMed/NCBI
|
